stockrowBruker Corporation
BRKR Healthcare Medical Devices
Bruker Corporation’s revenue for fiscal 2025 (year ended December 2025) was $3.4 billion, up 2.08% from fiscal 2024.
- Revenue
- +1.57%
- EPS
- −75.4%
- Free cash flow
- +278.7%
- Total debt
- −14.7%
Quarter to September 2026, against a year earlier
Follow BRKR
Alert me
Bruker Corporation (BRKR) Total debt
Bruker Corporation's total debt at the end of fiscal 2025 was $1.9B, down 10.8% from $2.1B in fiscal 2024. At the end of the quarter to 30 September 2026 it was $1.7B. Over the past ten years it has ranged from $265.8M (fiscal 2015) to $2.1B (fiscal 2024); the current reading is higher than 91% of that period. Bruker Corporation ranks 13th of 147 Medical Devices companies by total debt.
Total debt, annual
Embed this chart
Annual newest first
| Period | Total debt | Change |
|---|---|---|
| FY2025 | $1.9B | (10.75%) |
| FY2024 | $2.1B | 63.43% |
| FY2023 | $1.3B | 5.11% |
| FY2022 | $1.2B | (8.62%) |
| FY2021 | $1.3B | 57.99% |
| FY2020 | $844.5M | 3.84% |
| FY2019 | $813.3M | 138.43% |
| FY2018 | $341.1M | (17.93%) |
| FY2017 | $415.6M | 0.95% |
| FY2016 | $411.7M | 54.89% |
Quarterly newest first
| Period | Total debt | Change |
|---|---|---|
| Sep 2026 | $1.7B | (6.10%) |
| Jun 2026 | $1.8B | 9.18% |
| Mar 2026 | $1.7B | (10.58%) |
| Dec 2025 | $1.9B | (6.94%) |
| 43 more quarters | Free account |
Against its own ten years
Total debt against peers
| Company | Total debt |
|---|---|
| SNN Smith & Nephew SNATS, Inc. compare | $3.2B |
| BRKR Bruker Corporation | $1.7B |
| BIO.B Bio-Rad Laboratories, Inc. compare | $1.2B |
| BIO Bio-Rad Laboratories, Inc. compare | $1.2B |
| PODD Insulet Corporation compare | $962.1M |
| GMED Globus Medical, Inc. compare | $443.4M |
| TXG 10x Genomics compare | $98.0M |
| GKOS Glaukos Corporation compare | $66.9M |
| PEN Penumbra, Inc. compare | $19.0M |
What Total debt is
Total Debt tells an investor how much a company has borrowed in all, whether the money is due within a year or later.
Long Term Debt (Total) + Current Part of Debt
More on BRKR
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement